CCIA
MDGL icon

Campbell & Co Investment Adviser’s Madrigal Pharmaceuticals MDGL Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-718
Closed -$222K – 1209
2024
Q4 		$222K Buy
+718
New +$202K 0.02% 941
2023
Q4 		– Sell
-6,571
Closed -$960K – 1238
2023
Q3 		$960K Buy
+6,571
New +$1.24M 0.11% 282
2023
Q1 		– Sell
-1,438
Closed -$417K – 939
2022
Q4 		$417K Buy
+1,438
New +$141K 0.1% 397
2022
Q2 		– Sell
-13,196
Closed -$1.29M – 820
2022
Q1 		$1.29M Buy
+13,196
New +$1.11M 0.35% 42
2021
Q4 		– Sell
-5,000
Closed -$399K – 734
2021
Q3 		$399K Buy
+5,000
New +$432K 0.13% 284

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return